Dr. Reddy’s to Launch Generic Ozempic in Canada Within Days

Dr Reddy’s Laboratories Ltd. plans to launch its version of generic Ozempic this month, filling a void in the Canadian market months after a key patent expiry and paving the way for cheaper access to the GLP-1 drugs.

The Hyderabad-based firm would be the first to start selling its generic version in the country as it launches the therapy in the “next few days,” Chief Executive Officer Erez Israeli told reporters Tuesday. The firm is looking to sell the therapy at a “very healthy price,” Israeli said, without sharing further details on pricing.